Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Weifeng Tang, Yafeng Wang, Huiwen Pan, Hao Qiu & Shuchen Chen. (2019) Association of miRNA-499 rs3746444 A>G variants with adenocarcinoma of esophagogastric junction (AEG) risk and lymph node status. OncoTargets and Therapy 12, pages 6245-6252.
Read now
Read now
Jian Zhou, Jiangtao Zhu, Guojun Jiang, Juncheng Feng & Qianqian Wang. (2019) Downregulation of microRNA-4324 promotes the EMT of esophageal squamous-cell carcinoma cells via upregulating FAK. OncoTargets and Therapy 12, pages 4595-4604.
Read now
Read now
Articles from other publishers (26)
Rui Bergantim, Joana Jorge, Sara Peixoto da Silva, Raquel Alves, Ana Cristina Gonçalves, Ana Bela Sarmento-Ribeiro, José E. Guimarães & M. Helena Vasconcelos. 2024. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Kawthar Ali Radhi, Bassam Francis Matti & Israa Hussein Hamzah. (2023) The role of miRNA- 96 and miRNA-150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients. Human Gene 36, pages 201166.
Crossref
Crossref
Ahmed S. Doghish, Ahmed I. Abulsoud, Shereen Saeid Elshaer, Nourhan M. Abdelmaksoud, Mohamed Bakr Zaki, Hesham A. El-Mahdy, Ahmed Ismail, Doaa Fathi & Elsayed G.E. Elsakka. (2023) miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance– An emphasis on the interaction of signaling pathways. Pathology - Research and Practice 243, pages 154363.
Crossref
Crossref
Anas Ahmad, Summya Rashid, Anis Ahmad Chaudhary, Abdullah S. Alawam, Mohammad Ibrahim Alghonaim, Syed Shadab Raza & Rehan Khan. (2023) Nanomedicine as potential cancer therapy via targeting dysregulated transcription factors. Seminars in Cancer Biology 89, pages 38-60.
Crossref
Crossref
Hisham Al-Ward, Ning Liu, Moussa Omorou, Yiwei Huang, Wei Chen, Chun-Yang Liu, Shaochun Lv, Abduh Murshed, Fahmi Shaher, Yao Li, Yuxuan Zhang, Linxia Lu, Wenxia Gao, Yi Eve Sun & Hui Xu. (2023) The relationship between miRNA-210 and SCN1B in fetal rats with hypoxic-ischemic brain injury. Bioscience Reports 43:1.
Crossref
Crossref
Mohsen Karami Fath, Jalil Azami, Niloofar Jaafari, Mahsa Akbari Oryani, Nafiseh Jafari, Alireza Karim poor, Ali Azargoonjahromi, Mohsen Nabi-Afjadi, Zahra Payandeh, Hamidreza Zalpoor & Dariush Shanehbandi. (2022) Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid. Cellular & Molecular Biology Letters 27:1.
Crossref
Crossref
Kawthar Ali Radhi, Israa Hussein Hamzah & Bassam Francis Matti. (2022) The role of miRNA -181C between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients. Human Gene 34, pages 201128.
Crossref
Crossref
Yi Shen, Jin-Xing Liu, Meng-Meng Yin, Chun-Hou Zheng & Ying-Lian Gao. (2022) BMPMDA: Prediction of MiRNA-Disease Associations Using a Space Projection Model Based on Block Matrix. Interdisciplinary Sciences: Computational Life Sciences.
Crossref
Crossref
Sara Peixoto da Silva, Hugo R. Caires, Rui Bergantim, José E. Guimarães & M. Helena Vasconcelos. (2022) miRNAs mediated drug resistance in hematological malignancies. Seminars in Cancer Biology 83, pages 283-302.
Crossref
Crossref
Saman Sargazi, Bazla Siddiqui, Maimoona Qindeel, Abbas Rahdar, Muhammad Bilal, Razieh Behzadmehr, Shekoufeh Mirinejad & Sadanand Pandey. (2022) Chitosan nanocarriers for microRNA delivery and detection: A preliminary review with emphasis on cancer. Carbohydrate Polymers 290, pages 119489.
Crossref
Crossref
Md Salman Shakil, Mahruba Sultana Niloy, Kazi Mustafa Mahmud, Mohammad Amjad Kamal & Md Asiful Islam. (2022) Theranostic Potentials of Gold Nanomaterials in Hematological Malignancies. Cancers 14:13, pages 3047.
Crossref
Crossref
Elham Shirazi-Tehrani, Asma Vafadar, Majid Keshavarzi & Negar Firouzabadi. (2021) Anticancer properties of vincristine is modulated by microRNAs in acute lymphoblastic leukemia Nalm6 cell line. Anti-Cancer Drugs 33:1, pages e680-e685.
Crossref
Crossref
Fatemeh Yazarlou, Sepideh Kadkhoda & Soudeh Ghafouri-Fard. (2021) Emerging role of let-7 family in the pathogenesis of hematological malignancies. Biomedicine & Pharmacotherapy 144, pages 112334.
Crossref
Crossref
Olga Kersy, Mali Salmon-Divon, Ofer Shpilberg & Oshrat Hershkovitz-Rokah. (2021) Non-Coding RNAs in Normal B-Cell Development and in Mantle Cell Lymphoma: From Molecular Mechanism to Biomarker and Therapeutic Agent Potential. International Journal of Molecular Sciences 22:17, pages 9490.
Crossref
Crossref
Angela Avenoso, Salvatore Campo, Michele Scuruchi, Manuela Mania, Vanessa Innao, Angela D'Ascola, Giuseppe Mandraffino, Andrea G. Allegra, Caterina Musolino & Alessandro Allegra. (2021) Quantitative polymerase Chain reaction profiling of microRNAs in peripheral lymph-monocytes from MGUS subjects. Pathology - Research and Practice 218, pages 153317.
Crossref
Crossref
Asma Vafadar, Zahra Shabaninejad, Ahmad Movahedpour, Farzaneh Fallahi, Mona Taghavipour, Younes Ghasemi, Maryam Akbari, Alimohammad Shafiee, Sarah Hajighadimi, Sanaz Moradizarmehri, Ebrahim Razi, Amir Savardashtaki & Hamed Mirzaei. (2020) Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells. Cell & Bioscience 10:1.
Crossref
Crossref
Zhen Han, Steven T. Rosen & Christiane Querfeld. (2020) Targeting microRNA in hematologic malignancies. Current Opinion in Oncology 32:5, pages 535-544.
Crossref
Crossref
Tim Giles, Tommy van Limbergen, Panagiotis Sakkas, Lily Quinn, Aouatif Belkhiri, Dominiek Maes, Ilias Kyriazakis, Paul Barrow & Neil Foster. (2020) Diagnosis of sub-clinical coccidiosis in fast growing broiler chickens by MicroRNA profiling. Genomics 112:5, pages 3218-3225.
Crossref
Crossref
Wei Deng, Li Wang, Ming Pan & Jianping Zheng. (2020) The regulatory role of exosomes in leukemia and their clinical significance. Journal of International Medical Research 48:8, pages 030006052095013.
Crossref
Crossref
Ahmed S. Abdelhafiz, Ghada M. Elsayed, Magdy M. Saber, Abdallah Gameel & Nayera Hamdy. (2020)
Low expression of miR‐204 is associated with expression of CD34 and poor performance status in
denovo
AML
. International Journal of Laboratory Hematology 42:3, pages 263-269.
Crossref
Crossref
Ewelina Hermyt, Nikola Zmarzły, Beniamin Grabarek, Celina Kruszniewska-Rajs, Joanna Gola, Agnieszka Jęda-Golonka, Katarzyna Szczepanek, Urszula Mazurek & Andrzej Witek. (2019) Interplay between miRNAs and Genes Associated with Cell Proliferation in Endometrial Cancer. International Journal of Molecular Sciences 20:23, pages 6011.
Crossref
Crossref
Mingshan Niu, Ninghan Zhang, Rong Wang, Tingting Shao, Yuan Feng, Yangling Shen, Xuejiao Liu, Kai Zhao, Shengyun Zhu, Linyan Xu, Yao Yao & Kailin Xu. (2019) MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia. Frontiers in Oncology 9.
Crossref
Crossref
Ali Karami, Mohamad Sadeghian, Mina Azizi & Golnaz Asaadi Tehrani. (2019) Aberrant Promoter Hypermethylation of Mir34a and Mir200b Genes in Pediatric Acute Lymphoblastic Leukemia. Iranian Journal of Pediatrics 29:5.
Crossref
Crossref
Mei Mei, Yingjun Wang, Zhaoming Li & Mingzhi Zhang. (2019) Role of circular RNA in hematological malignancies (Review). Oncology Letters.
Crossref
Crossref
Qi Wang, Jiaqi Wang, Songtao Niu, Songsong Wang, Yibin Liu & Xiaoya Wang. (2019) MicroRNA-664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma. International Journal of Oncology.
Crossref
Crossref
Namrata S. Chandhok & Thomas Prebet. (2019) Insights into novel emerging epigenetic drugs in myeloid malignancies. Therapeutic Advances in Hematology 10, pages 204062071986608.
Crossref
Crossref